Investing First patient dosed in Phase IIb imaging for Brain Mets by admin April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement next post S&P 500 Rises from Bearish to Neutral, But Will It Last? You may also like McDermitt Project Fast-Tracked Under U.S. FAST-41 Initiative April 22, 2025 Alvo Minerals to Acquire Pan American’s Lavra Velha... April 1, 2025 $4,000 Gold on the Horizon? Why Smart Money... April 26, 2025 Major Finland Gold Transaction April 11, 2025 Top 5 Canadian Mining Stocks This Week: Euro... March 29, 2025 EU Deems Mkango and Euro Manganese Projects “Strategic”... March 27, 2025 Altech – CERENERGY Cells Test Safe Under Extreme... April 3, 2025 CEOL Application Process Update April 5, 2025 Are We in a Recession? Predictions, Signs and... April 29, 2025 13 Canadian Crypto ETFs in 2025 April 25, 2025